相关实验视频
Updated: Jun 6, 2025

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
1.6K
IL-6和心血管风险:叙述性审查
Nehal N Mehta1, Emil deGoma2, Michael D Shapiro3
1The George Washington University School of Medicine, Washington, DC, USA.
Current atherosclerosis reports
|November 26, 2024
概括
升高的IL-6水平预测心血管风险增加,包括死亡和重大不良事件. 这种炎症标志物与动脉样硬化进展和心力衰竭有关,支持IL-6抑制作为治疗点.
科学领域:
- 心血管医学 心血管医学
- 炎症生物学 炎症生物学
- 流行病学 流行病学
背景情况:
- 介乐-6 (IL-6) 是一种促炎性细胞因子,与各种疾病有关.
- 了解IL-6在心血管疾病 (CVD) 中的作用对于风险分层和治疗至关重要.
研究的目的:
- 审查最近关于循环IL-6水平与心血管结果之间的关联的前性观察性研究.
- 综合关于IL-6在临床和成像心血管终点中的作用的证据.
主要方法:
- 对前性观察性研究进行叙述性审查.
- 对将IL-6水平与心血管临床和成像终点联系起来的数据的分析.
主要成果:
- 较高的IL-6水平与心血管死亡,心肌梗塞,中风,周围动脉疾病和心力衰竭的风险增加有关.
- IL-6与动脉内心介质厚度和斑块进展,严重程度和脆弱性有关.
- 研究结果在不同人群中是一致的,并且在调整传统风险因素和高灵敏性C反应蛋白后是稳健的.
结论:
- IL-6是心血管风险的重要媒介,得到流行病学,遗传学和机理学数据的支持.
- 目前正在进行的试验正在研究IL-6抑制作为动脉样硬化心血管疾病和心力衰竭的治疗策略.
相关概念视频
Psychoneuroimmunology: Cardiovascular Disease
25
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
25
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
59
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
59
Assessment of the Cardiovascular System I: Subjective Data
278
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
278
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
3
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3

